首页>
外国专利>
NEW THERAPY FOR TRANSTHYRETIN-ASSOCIATED AMYLOIDOSIS.
NEW THERAPY FOR TRANSTHYRETIN-ASSOCIATED AMYLOIDOSIS.
展开▼
机译:促甲状腺素相关性淀粉样变性的新疗法。
展开▼
页面导航
摘要
著录项
相似文献
摘要
It is provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis. It is also provided a catechol-O-methyltransferase (COMT) inhibitor for use in the prevention and/or treatment of transthyretin-associated amyloidosis in combination therapy with another COMT inhibitor, a benzoxazole derivative, iododiflunisal, diflunisal, resveratrol, tauroursodeoxycholic acid, doxocycline, or epigallocatechin-3-gallate.
展开▼